Thumb

Innovations in Digital Adherence Technologies Improving TB Treatment Outcomes

Posted by Baraka Aloyce Onjare | March 20, 2025

Tuberculosis (TB) remains one of the world's deadliest infectious diseases, with treatment adherence being a critical factor in successful outcomes. At KNCV Tanzania, we have been at the forefront of implementing innovative Digital Adherence Technologies (DAT) that are transforming how TB patients manage their medication regimens and how healthcare providers monitor treatment progress.

Building on the ASCENT Project Success

Our work in digital adherence solutions builds upon the achievements of the ASCENT (Adherence Support Coalition to End TB) project, which ran from July 2019 to December 2022. This groundbreaking initiative implemented integrated DAT interventions across five countries, including Tanzania. The project demonstrated that digital technologies can significantly improve treatment adherence rates and patient outcomes while reducing the burden on healthcare systems.

Following the success of ASCENT, KNCV Tanzania has continued to expand DAT implementation across healthcare facilities throughout the country, focusing on sustainability and integration with existing health systems.

How Digital Adherence Technologies Work

Digital Adherence Technologies encompass several innovative approaches that help patients adhere to their TB treatment regimens:

  1. Smart Pill Boxes: These electronic devices remind patients when to take their medication and record when the box is opened, providing healthcare workers with real-time adherence data.

  2. Mobile Phone-Based Platforms: Using USSD (Unstructured Supplementary Service Data) technology, patients can report medication intake via simple mobile phones, making the technology accessible even in areas with limited smartphone penetration.

  3. Video Observed Therapy (VOT): Patients record themselves taking medication and submit the videos to healthcare providers, reducing the need for in-person visits while maintaining supervision.

  4. Medication Event Monitoring Systems: Electronic devices that track when medication bottles are opened, providing detailed adherence patterns to healthcare providers.

Integration with DHIS2

One of our major achievements has been integrating these technologies with Tanzania's DHIS2 (District Health Information Software 2) system. This integration allows for:

  • Real-time monitoring of patient adherence
  • Early identification of patients at risk of non-adherence
  • Data-driven decision making for healthcare providers
  • Reduced administrative burden on healthcare workers
  • Comprehensive reporting for program managers

Our team has developed a publicly available generic DHIS2 adherence app that healthcare facilities across Tanzania can implement, making this technology more accessible to facilities with limited resources.

Impact on TB Treatment Outcomes

The implementation of DAT in Tanzania has shown promising results:

  • Increased Treatment Success Rates: Facilities using DAT have reported up to 15% higher treatment success rates compared to traditional directly observed therapy methods.

  • Reduced Loss to Follow-Up: Early identification of adherence challenges has allowed healthcare providers to intervene promptly, reducing the number of patients who abandon treatment.

  • Cost-Effectiveness: Despite the initial investment in technology, DAT has proven cost-effective by reducing the need for frequent facility visits and allowing healthcare workers to focus on patients who need the most support.

  • Patient Empowerment: Patients report feeling more in control of their treatment journey, with the technology serving as both a reminder and a motivational tool.

Looking Ahead: Expanded Implementation

As we continue to refine these technologies, KNCV Tanzania is working on several fronts:

  1. Expanding Geographic Coverage: Bringing DAT to more rural and underserved areas across Tanzania.

  2. Building Local Capacity: Training healthcare workers and technical staff to maintain and troubleshoot the technologies.

  3. Adapting for Other Conditions: Exploring how similar approaches can benefit patients with other chronic conditions requiring long-term medication adherence.

  4. Policy Advocacy: Working with the Ministry of Health to include DAT in national TB treatment guidelines and secure sustainable funding for these initiatives.

At KNCV Tanzania, we believe that digital health innovations like DAT represent the future of TB care. By combining patient-centered approaches with appropriate technology, we can improve treatment outcomes, reduce the burden on healthcare systems, and move closer to our goal of ending TB in Tanzania.

For more information about our Digital Adherence Technology initiatives or to explore partnership opportunities, please contact us at info@kncv.co.tz.